Key departures shake EU drug regulatory network
This article was originally published in SRA
Executive Summary
While it is not a surprise in itself, the news that BfArM, the German drug and medical device regulator, is seeking a new president will serve to fuel a sense of unease over developments in the wider European drug regulatory network.